Detection of minimal residual disease using clonospecific primers for CDRIII in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples